Subcutaneous liraglutide ameliorates methylglyoxal-induced Alzheimer-like tau pathology and cognitive impairment by modulating tau hyperphosphorylation and glycogen synthase kinase-3β.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  American journal of translational research

• Publication date

  2017-02-15

• Fields of study

  Medicine

• Identifiers
  PMID 28337257PMCID PMC5340664
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Subcutaneous administration of liraglutide ameliorates learning and memory impairment by modulating tau hyperphosphorylation via the glycogen synthase kinase-3β pathway in an amyloid β protein induced alzheimer disease mouse model.

  2016cited by this paper
• Mitochondrial protection by the mixed muscarinic/σ1 ligand ANAVEX2-73, a tetrahydrofuran derivative, in Aβ25–35 peptide-injected mice, a nontransgenic Alzheimer’s disease model

  2015cited by this paper
• Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease.

  2015cited by this paper
• The GLP-1 Receptor Agonist Liraglutide Improves Memory Function and Increases Hippocampal CA1 Neuronal Numbers in a Senescence-Accelerated Mouse Model of Alzheimer’s Disease

  2015cited by this paper
• Alzheimer’s and Parkinson’s diseases: The prion concept in relation to assembled Aβ, tau, and α-synuclein

  2015cited by this paper
• Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.

  2014cited by this paper
• Neuroprotective and anti‐apoptotic effects of liraglutide on SH‐SY5Y cells exposed to methylglyoxal stress

  2014cited by this paper
• Specific Targeting of Tau Oligomers in Htau Mice Prevents Cognitive Impairment and Tau Toxicity Following Injection with Brain-Derived Tau Oligomeric Seeds

  2014cited by this paper
• Long-term ginsenoside Rg1 supplementation improves age-related cognitive decline by promoting synaptic plasticity associated protein expression in C57BL/6J mice.

  2014cited by this paper
• Glucagon-like peptide-1 protects hippocampal neurons against advanced glycation end product-induced tau hyperphosphorylation.

  2014cited by this paper
• Methylglyoxal, obesity, and diabetes

  2013cited by this paper
• The glyoxalase pathway: the first hundred years... and beyond.

  2013cited by this paper
• The glycolytic metabolite methylglyoxal induces changes in vigilance by generating low-amplitude non-REM sleep

  2013cited by this paper
• Methylglyoxal, cognitive function and cerebral atrophy in older people.

  2013cited by this paper
• Liraglutide improves hippocampal synaptic plasticity associated with increased expression of Mash1 in ob/ob mice

  2013cited by this paper
• Subcutaneous Administration of Liraglutide Ameliorates Alzheimer-Associated Tau Hyperphosphorylation in Rats with Type 2 Diabetes

  2013cited by this paper
• Hyperphosphorylation of tau protein by calpain regulation in retina of Alzheimer's disease transgenic mouse.

  2013cited by this paper
• Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation

  2013cited by this paper
• Role of Glyoxalase 1 (Glo1) and methylglyoxal (MG) in behavior: recent advances and mechanistic insights

  2012cited by this paper
• (Val⁸) glucagon-like peptide-1 prevents tau hyperphosphorylation, impairment of spatial learning and ultra-structural cellular damage induced by streptozotocin in rat brains.

  2012cited by this paper
• Glucagon-Like Peptide-1 Cleavage Product GLP-1(9-36) Amide Rescues Synaptic Plasticity and Memory Deficits in Alzheimer's Disease Model Mice

  2012influential reference
• Methylglyoxal Induces Tau Hyperphosphorylation via Promoting AGEs Formation

  2012cited by this paper
• Amyloid-β Metabolite Sensing: Biochemical Linking of Glycation Modification and Misfolding

  2012cited by this paper
• Epidemiology of Alzheimer disease.

  2012cited by this paper
• Early dysregulation of the mitochondrial proteome in a mouse model of Alzheimer's disease.

  2011cited by this paper
• P1‐109: Serum concentration of an inflammatory glycotoxin, methylglyoxal, is associated with increased cognitive decline in elderly individuals

  2011cited by this paper
• The Diabetes Drug Liraglutide Prevents Degenerative Processes in a Mouse Model of Alzheimer's Disease

  2011cited by this paper
• Alpha-synuclein deficiency leads to increased glyoxalase I expression and glycation stress

  2010cited by this paper
• Age-related loss of phospholipid asymmetry in APP(NLh)/APP(NLh) x PS-1(P264L)/PS-1(P264L) human double mutant knock-in mice: relevance to Alzheimer disease.

  2010cited by this paper
• Methylglyoxal‐mediated anxiolysis involves increased protein modification and elevated expression of glyoxalase 1 in the brain

  2010cited by this paper
• Tenuigenin protects cultured hippocampal neurons against methylglyoxal-induced neurotoxicity.

  2010cited by this paper
• Liraglutide

  2010cited by this paper
• Neuroscience: Alzheimer's disease

  2009cited by this paper
• Developmental regulation of tau phosphorylation, tau kinases, and tau phosphatases

  2009cited by this paper
• Receptors for the incretin glucagon-like peptide-1 are expressed on neurons in the central nervous system

  2009cited by this paper
• Oxidative stress in Alzheimer disease

  2009cited by this paper
• Impairment of synaptic plasticity and memory formation in GLP-1 receptor KO mice: Interaction between type 2 diabetes and Alzheimer's disease.

  2009cited by this paper
• Mechanisms of tau-induced neurodegeneration

  2009cited by this paper
• Microtubule-associated protein tau in development, degeneration and protection of neurons.

  2008influential reference
• GLP-1 agonists facilitate hippocampal LTP and reverse the impairment of LTP induced by beta-amyloid.

  2008cited by this paper
• Hydrogen Peroxide Promotes Aβ Production through JNK-dependent Activation of γ-Secretase*S⃞

  2008cited by this paper
• Caloric restriction and age affect synaptic proteins in hippocampal CA3 and spatial learning ability.

  2008cited by this paper
• RNA interference in silencing of genes of Alzheimer's disease in cellular and rat brain models.

  2008cited by this paper
• Oxidative stress hypothesis in Alzheimer's disease: a reappraisal.

  2008cited by this paper
• Role of GSK‐3β activation and α7 nAChRs in Aβ1–42‐induced tau phosphorylation in PC12 cells

  2008cited by this paper
• Genome-wide atlas of gene expression in the adult mouse brain

  2007cited by this paper
• Effect of Pseudophosphorylation and Cross-linking by Lipid Peroxidation and Advanced Glycation End Product Precursors on Tau Aggregation and Filament Formation*

  2007cited by this paper
• Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases

  2007cited by this paper
• Assessments of the accumulation severities of amyloid beta-protein and hyperphosphorylated tau in the medial temporal cortex of control and Alzheimer's brains.

  2006cited by this paper
• Morris water maze: procedures for assessing spatial and related forms of learning and memory

  2006cited by this paper
• Methylglyoxal, Glyoxal, and Their Detoxification in Alzheimer's Disease

  2005cited by this paper
• Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies.

  2005cited by this paper
• Anti-AGEing defences against Alzheimer's disease.

  2003cited by this paper
• Mitotic-like Tau Phosphorylation by p25-Cdk5 Kinase Complex*

  2003cited by this paper
• Glucagon‐like peptide 1 modulates calcium responses to glutamate and membrane depolarization in hippocampal neurons

  2003cited by this paper
• Glucagon-like peptide-1 receptor is involved in learning and neuroprotection

  2003cited by this paper
• Overactivation of glycogen synthase kinase‐3 by inhibition of phosphoinositol‐3 kinase and protein kinase C leads to hyperphosphorylation of tau and impairment of spatial memory

  2003cited by this paper
• Amyloid beta-protein fragment 31-35 forms ion channels in membrane patches excised from rat hippocampal neurons.

  2001cited by this paper
• Differential phosphorylation of tau proteins during kitten brain development and Alzheimer's disease

  2001cited by this paper
• Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose.

  1999cited by this paper
• Tau protein pathology in neurodegenerative diseases.

  1998cited by this paper
• The nervous system of ctenophores III. Ultrastructure of synapses

  1973cited by this paper
• Cellular Neuroscience

  year unknowncited by this paper

• Propyl Gallate Attenuates Methylglyoxal-Induced Alzheimer-like Cognitive Deficits and Neuroinflammation in Mice

  2026cites this paper
• Methylglyoxal Formation—Metabolic Routes and Consequences

  2025cites this paper
• HIF-1α serves as a co-linker between AD and T2DM.

  2024cites this paper
• Crosstalk between Alzheimer’s disease and diabetes: a focus on anti-diabetic drugs

  2023cites this paper
• Communal interaction of glycation and gut microbes in diabetes mellitus, Alzheimer's disease, and Parkinson's disease pathogenesis

  2023cites this paper
• Therapeutic Strategies for Tauopathies and Drug Repurposing as a Potential Approach.

  2022cites this paper
• The mechanism and efficacy of GLP-1 receptor agonists in the treatment of Alzheimer’s disease

  2022cites this paper
• The neuroprotective effects of glucagon-like peptide 1 in Alzheimer’s and Parkinson’s disease: An in-depth review

  2022cites this paper
• Liraglutide reduces oxidative stress and improves energy metabolism in methylglyoxal-induced SH-SY5Y cells.

  2022cites this paper
• The Role of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RA) in Diabetes-Related Neurodegenerative Diseases

  2022cites this paper
• The type 2 diabetes factor methylglyoxal mediates axon initial segment shortening and neuronal network activity changes

  2021cites this paper
• GLP-1 improves the neuronal supportive ability of astrocytes in Alzheimer's disease by regulating mitochondrial dysfunction via the cAMP/PKA pathway.

  2021cites this paper
• GLP-1 improves the supportive ability of astrocytes to neurons by promoting aerobic glycolysis in Alzheimer's disease

  2021cites this paper
• The Type 2 Diabetes Factor Methylglyoxal Mediates Axon Initial Segment Shortening and Alters Neuronal Function at the Cellular and Network Levels

  2021cites this paper
• Role of liraglutide in Alzheimer’s disease pathology

  2021cites this paper
• Pathological Mechanisms Linking Diabetes Mellitus and Alzheimer’s Disease: the Receptor for Advanced Glycation End Products (RAGE)

  2020cites this paper
• Type 2 Diabetes Mellitus Drugs for Alzheimer's Disease: Current Evidence and Therapeutic Opportunities.

  2020cites this paper
• Link between Diabetes and Alzheimer’s Disease Due to the Shared Amyloid Aggregation and Deposition Involving Both Neurodegenerative Changes and Neurovascular Damages

  2020cites this paper
• Potential roles of Glucagon-like peptide-1 and its analogues in cognitive impairment associated with type 2 diabetes mellitus.

  2020cites this paper
• Harnessing endophenotypes and network medicine for Alzheimer's drug repurposing

  2020cites this paper
• Progress of RAGE Molecular Imaging in Alzheimer’s Disease

  2020cites this paper
• Neurexin and neuroligins jointly regulate synaptic degeneration at the Drosophila neuromuscular junction based on TEM studies

  2020influential citation
• The impact of anorexigenic peptides in experimental models of Alzheimer's disease pathology.

  2019cites this paper
• GLP-1’s role in neuroprotection: a systematic review

  2019cites this paper
• Antidiabetic treatment on memory and spatial learning: From the pancreas to the neuron

  2019cites this paper
• Methylglyoxal and Glyoxal as Potential Peripheral Markers for MCI Diagnosis and Their Effects on the Expression of Neurotrophic, Inflammatory and Neurodegenerative Factors in Neurons and in Neuronal Derived-Extracellular Vesicles

  2019cites this paper
• Liraglutide Ameliorates Hyperhomocysteinemia-Induced Alzheimer-Like Pathology and Memory Deficits in Rats via Multi-molecular Targeting

  2019cites this paper
• Current and Prospective Treatments for Alzheimer's Disease (and Other Neurodegenerative Diseases)

  2019cites this paper
• The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non‐human primate model of Alzheimer's disease

  2018cites this paper
• Neuroprotective Actions of Glucagon-Like Peptide-1 (GLP-1) Analogues in Alzheimer’s and Parkinson’s Diseases

  2018cites this paper
• Novel Lipidized Analog of Prolactin-Releasing Peptide Improves Memory Impairment and Attenuates Hyperphosphorylation of Tau Protein in a Mouse Model of Tauopathy

  2018cites this paper
• Role of the Glyoxalase System in Alzheimer’s Disease

  2018cites this paper
• Recent update on biological activities and pharmacological actions of liraglutide

  2017cites this paper